002038 双鹭药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.505-1.3027.3964.3498.282
总资产报酬率 ROA (%)2.350-1.2096.8574.0297.637
投入资产回报率 ROIC (%)2.438-1.2767.2774.2908.190

边际利润分析
销售毛利率 (%)61.59767.97081.56085.05484.889
营业利润率 (%)35.320-18.11046.92625.07437.664
息税前利润/营业总收入 (%)33.789-21.37944.19423.27636.336
净利润/营业总收入 (%)30.655-11.40040.74821.74334.682

收益指标分析
经营活动净收益/利润总额(%)10.153-29.16454.32773.45855.689
价值变动净收益/利润总额(%)88.012119.00351.51038.53545.651
营业外收支净额/利润总额(%)-1.99610.577-2.791-1.5290.064

偿债能力分析
流动比率 (X)12.3738.6007.0726.9167.071
速动比率 (X)10.4847.7496.6856.4436.687
资产负债率 (%)5.4406.6637.4506.7507.538
带息债务/全部投入资本 (%)0.8900.4860.091-0.435-0.813
股东权益/带息债务 (%)10,907.82120,066.410108,232.141-22,658.472-12,144.326
股东权益/负债合计 (%)1,735.9021,398.8081,240.1781,378.7341,223.188
利息保障倍数 (X)-40.22318.970-30.320-16.394-26.884

营运能力分析
应收账款周转天数 (天)56.90182.70380.077102.567117.306
存货周转天数 (天)491.297332.536269.611300.065232.252